Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




MRI Can Detect Transplant Rejection

By HospiMedica staff writers
Posted on 31 Jan 2006
Scientists have developed a promising tool that utilizes magnetic resonance imaging (MRI) to track immune cells as they penetrate a transplanted heart in the early stages of organ rejection. More...


This pre-clinical development, described in the January 24, 2006, issue of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS), could ultimately provide a non-invasive way to identify transplant rejection in patients.

"We have reported for the first time the ability to monitor single immune cells in a live animal using MRI. This could revolutionize the management of transplant patients,” stated Dr. Chien Ho, professor of biological sciences at the Mellon University College of Science (Pittsburgh, PA, USA) and director of the Pittsburgh NMR Center for Biomedical Research. "Successful translation of this work to the clinic ultimately will reduce the number of biopsy procedures and should greatly improve the quality of life for cardiac transplant patients, especially children. Perhaps most importantly, this advance will allow doctors to provide highly personalized care that could prevent transplant rejection.”

Organ transplantation is the favored clinical approach to treat end-stage organ failure; however, transplant patients face a lifetime of immunosuppressive therapy and the risk of losing the new organ because of rejection. Dr. Ho's unique application examines transplant rejection non-invasively by monitoring macrophage accumulation in heart tissues using MRI. "We were able to use MRI to visualize individual macrophages. By tracking individual cells, we also were able to observe, for the first time, that rejection progresses from the outside of the heart to the inside,” stated Dr. Ho.

For the study, Dr. Yijen Wu, a research biologist at the Pittsburgh NMR Center for Biomedical Research, tagged macrophages with nanometer (USPIO), or micrometer (MPIO)-sized paramagnetic iron oxide particles, which are very sensitive to the magnetic fields used during MRI. Dr. Wu injected the MPIO or USPIO particles into laboratory rats that had received heart transplants three days earlier. Macrophages, which usually ingest foreign substances inside the body (such as bacteria), incorporated the particles. Utilizing MRI, the researchers then track tagged macrophages that infiltrated transplanted hearts. The researchers used a heterotropic heart model to assess organ rejection. In this model, a rat received a second functional heart, which was grafted into its abdomen. In this manner, the investigators can evaluate how a transplanted heart changes through sequential stages of rejection while the rat remains healthy.





Related Links:
Mellon University College of Science

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.